Vilma Dembitz

9PUBLICATIONS
94CO-AUTHORS
Haematological tumoursMolecular targetsMedical molecular engineering of nucleic acids and proteinsCancer diagnosisBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 24, 2026
Roles of RRM2 and RRM2B in pyrimidine stress responses and differentiation of acute myeloid leukemia cells.

|Sep 16, 2024
Bone marrow stromal cells enhance differentiation of acute myeloid leukemia induced by pyrimidine synthesis inhibitors.

Tomislav Smoljo, Hrvoje Lalic, Vilma Dembitz

|Aug 26, 2024
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation.

Vilma Dembitz, Hannah Lawson, Richard Burt

|Apr 18, 2024
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.

Hannah Lawson, James P Holt-Martyn, Vilma Dembitz

|Apr 14, 2023
Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death.

Keith Woodley, Laura S Dillingh, George Giotopoulos

|Apr 03, 2023
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia.

Marie Sabatier, Rudy Birsen, Laura Lauture

Pageof 2

Frequent Collaborators

5 joint publications

Paolo Gallipoli

3 joint publications

Dora Visnjic

3 joint publications

Hrvoje Lalić

3 joint publications

Tomislav Smoljo